# reload+after+2024-01-21 08:47:35.541908
address1§14/15 Conduit Street
city§London
zip§W1S 2XJ
country§United Kingdom
website§https://www.tizianalifesciences.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It also develops Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-  receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation and to treat COVID-19 patients. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.Kingdom.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Gabriele Marco Antonio Cerrone M.B.A.', 'age': 51, 'title': 'Founder, Executive Chairman & Interim CEO', 'yearBorn': 1972, 'fiscalYear': 2022, 'totalPay': 444000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Andrea  Brancale', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Richard  Clarkson Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Andrew  Westwell Ph.D.', 'title': 'Scientific Founder', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Keeren  Shah', 'age': 46, 'title': 'Chief Financial Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Matthew W. Davis M.D., R.Ph.', 'title': 'COO & Chief Medical Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. William A. Clementi Ph.D., Pharm.D.', 'title': 'Chief Development Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Napoleone  Ferrara M.D.', 'age': 66, 'title': 'Member of Scientific Advisory Board', 'yearBorn': 1957, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§0.307
currency§USD
dateShortInterest§1702598400
forwardEps§-0.05
exchange§NCM
quoteType§EQUITY
shortName§Tiziana Life Sciences Ltd
longName§Tiziana Life Sciences Ltd
firstTradeDateEpochUtc§1542724200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§25281967-9322-3f3e-9012-ef32a973842d
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§3.678
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
